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Highly Enantioselective, Organocatalytic and Scalable Synthesis 
of a rare cis-cis-Tricyclic Diterpenoid 
Daniel Townsend,[a] Kenneth Shankland,[b] Alex Weymouth-Wilson,[c] Zofia Komsta,[c] Tim Evans,[c] and 
Alexander J. A. Cobb*[a] 
Abstract: A highly enantioselective, organocatalytic and scalable 
synthesis of a very unusual cis-decalin-cis-hydrindane tricyclic 
diterpenoid system has been achieved. Despite the prevalent 
pharmacological space that the related trans-trans and trans-cis-
systems occupy, there have been no reports of an asymmetric 
synthesis of the cis-cis systems in the literature until now. We 
demonstrate the flexibility of our approach not only through access to 
a diverse range of products, all of which are attained in exceptionally 
high selectivities, but also by showing their easy conversion to the 
corresponding trans-cis-system and other derivatives. 
Diterpenes and triterpenes such as steroids are amongst the most 
important and well-studied class of biomolecule owing to their 
incredibly broad biological properties, their fascinating chemistry, 
and their spectrum of therapeutic potential.[1] Although tricyclic 
systems whereby there exists a decalin unit fused to a hydrindane 
one only occur in a handful of diterpenes discovered thus far – 
e.g. verrucosane,[2] neoverrucosane[3] and the stellettins (Figure 
1a),[4] this tricyclic arrangement is ubiquitous within almost every 
steroidal system known. Referred to as the BCD ring system, 
these three rings are the source of most of the structural diversity 
within steroidal systems (Figure 1b). It is no surprise, therefore, 
that the expedient synthesis of these scaffolds has been the focus 
of much study over the last half century.[5]  
 
 
Figure 1: Example natural product frameworks where a decalin is fused to a 
hydrindane 
Nevertheless, although in synthetic terms the trans-decalin-trans-
hydrindanes and to a lesser extent the trans-decalin-cis-
hydrindane systems (as occur in the cardenolides) are well 
established, other stereochemical variations are extremely rare. 
This is astonishing given that alternative unnatural configurations 
offer the potential to explore new pharmacological space. 
Specifically, examples of a cis-decalin fused to a cis-hydrindane 
are extremely rare; either in steroidal syntheses or otherwise.[6] In 
fact, we could find just three examples of this framework in the 
literature, none of which were enantioselective or capable of 
achieving any significant structural diversity. Pattenden and co-
workers serendipitously accessed the steroidal target containing 
this fragment via a radical cascade reaction (Figure 2a).[6a] The 
second example by Deslongchamps and co-workers led to three 
different isomers of these systems via a transannular Diels-Alder 
reaction (Figure 2b).[6b] Finally, Kocór and co-workers 
demonstrated a dynamic kinetic resolution a cardenolide-like 
precursor to give the corresponding cis-decalin-cis-hydrindane 
(Figure 2c).[6c] Our approach to constructing this system was to 
use organocatalytic methodology - specifically using the nitro 
group as a handle – a functionality we have exploited with some 
success in the past.[7] In addition, we felt that not only would this 
unique cis-cis tricyclic structure enable the exploration of 
undiscovered chemical space, but would also be dynamic enough 
as a central fragment to derivatize easily to other terpenoid 
structures, owing to the orthogonal reactivity of the functional 
group handles on each ring system. 
 
Figure 2 : None of the three literature examples of cis-decalin-cis-hydrindane 
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In our design we sought to use asymmetric aminocatalysis to 
encourage an enantioselective Michael addition of 
nitrocyclopentadione 2 to cyclohexanone 1. We hoped that the 
resulting enolate would undergo an intramolecular 
desymmetrising aldol reaction with the resulting dione to form the 
desired tricyclic system. The latter part of this sequence is of 
course known, originating from the works of Hajos-Parrish[8] and 
Eder, Sauer and Wiechert.[9] More recently, the excellent work of 
both Nagorny[10] and Deslongchamps[11] constructed the cis-
hydrindane, fused to a trans-decalin in a variety of cardenolides 
through such a desymmetrising process, giving us hope that this 
approach would be valid for our target. 
 
To test the feasibility of our hypothesis, our investigation began 
by screening the reaction of 1 and 2 with a range of catalytic 
systems, each of which have been utilized to varying degrees of 
success in conjugate addition chemistry, along with 3-
nitrobenzoic acid as a co-catalyst additive (Table 1). Surprisingly, 
neither the Hayashi-Jørgensen[12] I, nor the MacMillan[13] II 
systems catalyzed the process to any degree (Entries 1 and 2). 
Bifunctional thiourea systems III were also unsuccessful (Entry 
3).[14] To our delight, however, proline IV, proline tetrazole[15] V and 
the primary amine cinchona alkaloid[16]  VI gave us the product we 
desired (Entries 4-6).  
Whilst the proline catalysts only directed the reaction with 
moderate selectivity, we were very pleased to see that the well-
established conjugate addition catalyst VI was able to control the 
reaction with exceptional stereocontrol. Interestingly, for all 
catalysts IV to VI, the tricyclic product was produced as a single 
diastereoisomer, whilst the acyclic intermediate 4, representing 
the majority of the product, was obtained in a 1:1 dr, suggesting 
epimierization under the reaction conditions. In the case of 
catalyst VI, these diastereoisomers were produced as single 
enantiomers.  
The absolute stereochemistry of tricyclic system 3, showing 
the cis-cis arrangement of the system (Figure 3) was established 
by reference to tricyclic system 6 (Figure 6), whose absolute 
stereochemistry was determined unambiguously by X-ray 
crystallography.  
 
Figure 3 : One of the two unique molecules in the asymmetric unit of the crystal 
structure of tricyclic adduct 3a. The other molecule differs only in terms of the 
rotation of the nitro group (CCDC : 1967524) 
Our attention then focused on improving the yield of the reaction, 
Although the organocatalyst was unable to push the reaction all 
the way to the tricycle, we theorized that if we could optimize the 
formation of acyclic intermediate product 4, which was the major 
product anyway, we could then force the subsequent cyclization 
using alternative conditions (Table 2). It was found that the co-
catalyst used was critical to the success of the reaction, and that 
changing the solvent also had a profound effect on yield. The 
Table 1.  Organocatalyst screen for the Michael-Aldol sequence between 










ee 4a  
(%)[c] 
1 I  0 - 0 - 
2 II  0 - 0 - 
3 III  0 - 0 - 
4 IV  8 -52 16 nd 
5 V  12 -42 18 nd 
6 VI  12 >99 58 >99,>99 
[a] Reactions performed on a 1mmol scale [b] Isolated as a mixture of 
diastereoisomers [c] Determined by chiral HPLC analysis  
    
Table 2.  Solvent screen for the Michael addition between cyclohexenone 1 













ee 4  
(%)[c] 
1 CH2Cl2 1 : 1 2-FBA 23 168 0 - 
2 CH2Cl2 1 : 1 AcOH 23 168 0 - 
3 CH2Cl2 1 : 1 p-TSA 23 168 0 - 
4 MeCN 1 : 1 3-NBA 23 96 32 92, 96 
5 PhMe 1 : 1 3-NBA 23 24 41 95, 98 
6 CHCl3 1 : 1 3-NBA 23 72 59 97, 98 
7 THF 1 : 1 3-NBA 23 72 48 >99, >99 
8 MeOH 1 : 1 3-NBA 23 24 43 86, 91 
9 CH2Cl2 1 : 1 3-NBA 40 24 55 96, 96 
10 CH2Cl2 2 : 3 3-NBA 23 48 59 >99, >99 
11 CH2Cl2 2 : 1 3-NBA 23 48 70 >99, >99 
[a] Reactions performed on a 1mmol scale [b] Isolated as a 1:1 mixture of 
diastereoisomers as determined by 1H NMR [c] Determined by chiral HPLC 
analysis. 
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most significant effect on selectivity, however, came from the 
stoichiometry of the process, with two equivalents of cyclohexene 
giving Michael adduct 4 in exceptional enantioselectivity. 
 
With an excellent synthesis of tricyclic precursor 4 in hand, we 
then went on to examine conditions to enable the cyclization. 
Whilst both Brønsted acid and base conditions led to substrate 
degradation, primarily through a retro-Michael pathway,[17] we 
were delighted to discover that a screen of Lewis Acids resulted 
in the formation of the desired adduct, observed previously (Table 
3). The initial catalyst screen resulted in the observation of 
elimination product 5, but a screen of solvent, temperature and 
stoichiometry led to us finding the optimal conditions for the 
exclusive formation of the cis-decalin-cis-hydrindane 3a in good 
yield. 
 
Table 3. Lewis acid screen for the Aldol cyclization of 4a.[a] 
 
Entry Lewis Acid (eqs) Solvent T, h Yield 3, % Yield 5, % 
1 SnCl4 (1.2) CH2Cl2 72 0 0 
2 BF3.OEt2 (1.2) CH2Cl2 24 33 17 
3 TiCl4 (1.2) CH2Cl2 72 0 0 
4 AlCl3 (1.2) CH2Cl2 72 8 6 
5 BF3.OEt2 (1.2) PhMe 96 17 25 
6 BF3.OEt2 (1.2) MeCN 96 53 4 
7 BF3.OEt2 (2) MeCN 5 79 0 
8 BF3.OEt2 (3) MeCN 5 73 0 
[a] Reactions performed on a 0.7 mmol scale. 
With our optimized conditions in hand, we examined the 
generality of this process using a range of different substrates as 
shown in Table 4. We were very pleased to observe that the 
selectivities were excellent for all substrates, showing only a 
single diastereoisomer and >99% enantiomeric excess for most. 
Remarkably, there appear to be no general methodologies to 
allow for variation in the substituent at the hydrindane bridgehead 
position of any terpene or steroidal target. Indeed, the only 
departure from methyl at that position appear to be the 
progestone oral contraceptives, which have ethyl or 
hydroxymethyl variations at that position. Our methodology 
addresses this paucity and thus opens the door to greater 
pharmacological space. We have successfully introduced larger 
substituents such as isopropyl (3b) and 1-napthyl (3h) in good 
yield and excellent selectivity, as well as thiophene (3g), benzyl 
(3e) and para-chlorbenzyl (3i) which are all capable of further 
derivation. Pleasingly, we also used our methodology to 
successfully access the D-homosteroid-like system (3j) – again in 
excellent diastereo- and enantioselectivity.[21] Use of 
cycloheptene in place of partner 1 gave the single addition 
product 4k – again in 1:1 dr and excellent enantioselectivities for 
both diastereoiomers – but unfortunately did not cyclize to the 
tricyclic system under our current conditions. 
 












[a] Reactions scales vary depending on substrate, see SI for details. Ee 
determined by chiral HPLC analysis. 
 
 
Figure 4 : Although the stereoselective outcome of our process fits the 
model of Melchiorre (Figure 4a, ref 17), our stoichiometry and co-catalyst 
are slightly different.  (b) Bifunctional activation of the enone and nucleophile 
is also a possibility (ref 16). 
Although the origin of stereochemistry in the Michael addition 
fits the model proposed by Melchiorre and co-workers (Figure 
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amine catalyst, we found that better yields were obtained in a 
1:2 ratio (Table 1, Entry 11). We therefore do not discount the 
possibility of a bifunctional effect of the catalyst on the 
enantioselective outcome (Figure 4b), as has been described 
for other related processes,[16] although further study is 
required. Under the reaction conditions, the -proton of the 
nitro group epimerizes, giving a 1:1 mix of diastereoisomers as 
is evident in Table 2. This epimerization also occurs under the 
subsequent Lewis acid conditions, which is a critical point 
because we theorize that only one of these epimers is able to 
cyclize under these conditions. This is demonstrated in Figure 
5, where both epimers are shown in the conformations they are 
required to adopt in order to cyclize. Our main assumption is 
that in both, the large nitro group must adopt an equatorial-like 
position in the transition state. For the preferred (R)-epimer 
(Figure 5a), this sets up the stereoelectronic requirements for 
favourable axial attack. As one might expect, this also sets up 
the preference for the reacting group to approach from the face 
on which it resides, giving the observed cis-geometry. In the 
case of the (S)-epimer, the nitro group is again assumed to 
prefer an equatorial-like position (Figure 5b), but this time in 
order for the corresponding nitronate to react, it needs to come 
in from the anti-face. This is very unfavorable owing to the 
resulting steric demands where there is a steric clash between 
the -hydrogen and the reacting carbonyl. Thus, as the 
substrate epimerizes, and more of the favored epimer is 
generated, the reaction is driven towards the cyclized product. 
 
 
Figure 5 : The requirement for the nitro-functionality to reside in a pseudo-
equatorial position means that only one of the two epimers is set up to cyclize. 
Since the starting material epimerises under the reaction conditions, this means 
that the overall reaction is driven toward the formation of the preferred epimer 
and thus the cyclized product.  (a) The reactive epimer leads to the cis-cis-
tricycle. (b) The other epimer does not have the steric or stereoelectronic 
requirements to cyclize. 
 
In order to demonstrate that it was also possible to access the 
more common trans-decalin-cis-hydrindane from these systems, 
we subjected tricyclic system 3a to HCl gas in dichloromethane 
and pleasingly obtained the corresponding C-10 epimer 6 
(Scheme 1). Interestingly, this leads to the nitro-group going from 
an equatorial position to an axial one (Figure 6), which is 
demonstrated by the fact that treatment of compound 6 with 
imidazole leads to C-6 epimer 7 where the nitro group is now in a 
preferred, thermodynamically favourable equatorial position. 
Finally, we have also demonstrated that the nitro-group can be 
removed altogether via a radical denitration to obtain tricycle 8, 
and that it is possible to discriminate between the two ketones of 
the product by selective acetal protection of the cyclohexanone. 
 
 
Scheme 1. Epimerization of tricycle 3a and subsequent transformations. 
 
Figure 6 : X-Ray crystal structure of the epimerized trans-decalin-cis 
hydrindane system 6, showing that the nitro group is now axial (CCDC: 
1967525) 
In conclusion, we have developed the first enantioselective 
synthesis of a cis-decalin-cis-hydrindane tricycle. Adducts were 
obtained in exceptionally good selectivities and a model 
rationalizing this is proposed. It was also shown that we could 
access a diverse range of structural configurations, such as the 
C9-C10 unsaturated system 5 and the C10-epimer 6. We also 
showed it was possible to epimerize the nitro group effectively, as 
well as remove it altogether. Future work will focus on examining 
the biological activity of these systems and their derivatives as 
well as utilizing them towards the synthesis of cardenolide 
analogues. 
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The highly enantioselective synthesis of a tricyclic terpenoid system is described with 
a remarkable cis-cis-configuration of the fused decalin and hydrindane systems. This 
intriguing selectivity is thought to be due to the nitro-group dictating the transition 
state of the cyclization adopted.  
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